DK3719013T3 - Pyrimidinsulfamidderivat og fremgangsmdåde til fremstilling og medicinsk anvendelse heraf - Google Patents
Pyrimidinsulfamidderivat og fremgangsmdåde til fremstilling og medicinsk anvendelse heraf Download PDFInfo
- Publication number
- DK3719013T3 DK3719013T3 DK18881280.4T DK18881280T DK3719013T3 DK 3719013 T3 DK3719013 T3 DK 3719013T3 DK 18881280 T DK18881280 T DK 18881280T DK 3719013 T3 DK3719013 T3 DK 3719013T3
- Authority
- DK
- Denmark
- Prior art keywords
- production
- medical use
- sulfamide derivative
- pyrimidine
- pyrimidine sulfamide
- Prior art date
Links
- GZRPWFCHDLJSDX-UHFFFAOYSA-N pyrimidine;sulfamide Chemical class NS(N)(=O)=O.C1=CN=CN=C1 GZRPWFCHDLJSDX-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711168111 | 2017-11-21 | ||
| PCT/CN2018/116196 WO2019101039A1 (zh) | 2017-11-21 | 2018-11-19 | 嘧啶磺酰胺类衍生物、其制备方法及其在医药上的应用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3719013T3 true DK3719013T3 (da) | 2023-04-03 |
Family
ID=66630436
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18881280.4T DK3719013T3 (da) | 2017-11-21 | 2018-11-19 | Pyrimidinsulfamidderivat og fremgangsmdåde til fremstilling og medicinsk anvendelse heraf |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US11319305B2 (da) |
| EP (1) | EP3719013B1 (da) |
| JP (1) | JP7245832B2 (da) |
| CN (1) | CN111479808B (da) |
| AU (1) | AU2018372752B2 (da) |
| BR (1) | BR112020010149A8 (da) |
| CA (1) | CA3083019A1 (da) |
| DK (1) | DK3719013T3 (da) |
| ES (1) | ES2936864T3 (da) |
| FI (1) | FI3719013T3 (da) |
| HR (1) | HRP20230318T1 (da) |
| HU (1) | HUE061515T2 (da) |
| IL (1) | IL274773B2 (da) |
| LT (1) | LT3719013T (da) |
| PL (1) | PL3719013T3 (da) |
| PT (1) | PT3719013T (da) |
| RS (1) | RS64040B1 (da) |
| SI (1) | SI3719013T1 (da) |
| WO (1) | WO2019101039A1 (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109232546B (zh) * | 2018-09-25 | 2020-09-04 | 中国人民解放军总医院 | 一种嘧啶磺酰胺类衍生物的医药用途 |
| US20220220098A1 (en) * | 2019-05-22 | 2022-07-14 | Wuxi Biocity Biopharmaceutics Co., Ltd. | Crystal form of pyrimidine sulfonamide compound and preparation method therefor |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2315614C (en) * | 1999-07-29 | 2004-11-02 | Pfizer Inc. | Pyrazoles |
| CA2348847A1 (en) * | 2000-05-31 | 2001-11-30 | Pfizer Inc. | New isoxazole-sulfonamide endothelin antagonists |
| JP3490959B2 (ja) | 2000-07-11 | 2004-01-26 | 三洋電機株式会社 | 受光素子及び受光モジュール |
| CN100432070C (zh) * | 2000-12-18 | 2008-11-12 | 埃科特莱茵药品有限公司 | 新颖的磺酰胺类化合物及其作为内皮素受体拮抗剂的应用 |
| AU2003285321B2 (en) | 2002-12-02 | 2010-04-08 | Actelion Pharmaceuticals Ltd | Pyrimidine-sulfamides and their use as endothelian receptor antagonist |
| TW200628467A (en) * | 2004-11-11 | 2006-08-16 | Actelion Pharmaceuticals Ltd | Novel sulfamides |
-
2018
- 2018-11-19 SI SI201830884T patent/SI3719013T1/sl unknown
- 2018-11-19 HR HRP20230318TT patent/HRP20230318T1/hr unknown
- 2018-11-19 FI FIEP18881280.4T patent/FI3719013T3/fi active
- 2018-11-19 CN CN201880074739.3A patent/CN111479808B/zh active Active
- 2018-11-19 HU HUE18881280A patent/HUE061515T2/hu unknown
- 2018-11-19 JP JP2020528076A patent/JP7245832B2/ja active Active
- 2018-11-19 US US16/764,654 patent/US11319305B2/en active Active
- 2018-11-19 BR BR112020010149A patent/BR112020010149A8/pt unknown
- 2018-11-19 PL PL18881280.4T patent/PL3719013T3/pl unknown
- 2018-11-19 WO PCT/CN2018/116196 patent/WO2019101039A1/zh unknown
- 2018-11-19 PT PT188812804T patent/PT3719013T/pt unknown
- 2018-11-19 RS RS20230197A patent/RS64040B1/sr unknown
- 2018-11-19 AU AU2018372752A patent/AU2018372752B2/en active Active
- 2018-11-19 EP EP18881280.4A patent/EP3719013B1/en active Active
- 2018-11-19 LT LTEPPCT/CN2018/116196T patent/LT3719013T/lt unknown
- 2018-11-19 CA CA3083019A patent/CA3083019A1/en active Pending
- 2018-11-19 DK DK18881280.4T patent/DK3719013T3/da active
- 2018-11-19 ES ES18881280T patent/ES2936864T3/es active Active
-
2020
- 2020-05-19 IL IL274773A patent/IL274773B2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2021504330A (ja) | 2021-02-15 |
| CN111479808A (zh) | 2020-07-31 |
| EP3719013A1 (en) | 2020-10-07 |
| AU2018372752B2 (en) | 2023-02-02 |
| CA3083019A1 (en) | 2019-05-31 |
| BR112020010149A8 (pt) | 2023-01-17 |
| IL274773B2 (en) | 2023-08-01 |
| EP3719013B1 (en) | 2023-01-04 |
| US11319305B2 (en) | 2022-05-03 |
| RU2020119900A (ru) | 2021-12-23 |
| HUE061515T2 (hu) | 2023-07-28 |
| LT3719013T (lt) | 2023-05-10 |
| IL274773B1 (en) | 2023-04-01 |
| EP3719013A4 (en) | 2021-04-21 |
| SI3719013T1 (sl) | 2023-05-31 |
| HRP20230318T1 (hr) | 2023-05-12 |
| WO2019101039A1 (zh) | 2019-05-31 |
| RU2020119900A3 (da) | 2021-12-23 |
| AU2018372752A1 (en) | 2020-07-02 |
| ES2936864T3 (es) | 2023-03-22 |
| IL274773A (en) | 2020-07-30 |
| PT3719013T (pt) | 2023-02-01 |
| RS64040B1 (sr) | 2023-04-28 |
| PL3719013T3 (pl) | 2023-05-08 |
| BR112020010149A2 (pt) | 2020-11-10 |
| JP7245832B2 (ja) | 2023-03-24 |
| CN111479808B (zh) | 2023-02-24 |
| FI3719013T3 (fi) | 2023-04-03 |
| US20200283425A1 (en) | 2020-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3448386T3 (da) | Isoquinolin-3-ylcarboxamider og fremstilling og anvendelse deraf | |
| DK3452463T3 (da) | Amidsubstituerede pyridinyltriazolderivater og anvendelser deraf | |
| DK3340981T3 (da) | Aryl, heteroaryl og heterocykliske forbindelser til behandling af medicinske forstyrrelser | |
| DK3292150T3 (da) | Aktiverbare anti-cd166-antistoffer og fremgangsmåder til anvendelse deraf | |
| DK3360878T3 (da) | Azetidinderivat, fremstillingsfremgangsmåde derfor og anvendelse deraf | |
| DK3558116T3 (da) | Kontinuerlig glukosemonitoreringssystem og fremgangsmåde | |
| DK3141199T3 (da) | Medicinsk mikrorobot og mikrorobotsystem med samme | |
| DK3319611T3 (da) | Oxysteroler og fremgangsmåder til anvendelse deraf | |
| DK3511019T3 (da) | Terapeutiske nanopartikler omfattende et terapeutisk middel og fremgangsmåder til fremstilling og anvendelse deraf | |
| DK3319612T3 (da) | Oxysteroler og fremgansmåder til anvendelse derfor | |
| DK3481581T3 (da) | Metalwiretilførselssystem og fremgangsmåde | |
| DK3436022T3 (da) | Oxysteroler og fremgangsmåder til anvendelse heraf | |
| DK3142785T3 (da) | Fremgangsmåde til fremstilling af alkenoler og anvendelse deraf til fremstilling af 1,3-butadien | |
| DK3345587T3 (da) | Beholderholdeelement og medicinsk beholdersæt | |
| DK3514153T3 (da) | Pyrimidinforbindelse og farmaceutisk anvendelse deraf | |
| DK3424924T3 (da) | Ureaforbindelse, fremgangsmåde til fremstilling deraf og medicinsk anvendelse deraf | |
| DK3094640T3 (da) | Fremgangsmåder til steril kromatografi og fremstilling | |
| DK3265641T3 (da) | Stigørenhed og fremgangsmåde | |
| DK3236991T3 (da) | Fgf21-derivater og anvendelser deraf | |
| DK3178324T3 (da) | Mikrobicid og fremgangsmåde til fremstilling af samme | |
| DK3100050T3 (da) | Immobiliserede proteiner og anvendelse deraf | |
| DK3612579T3 (da) | Pultrudat, fremstilling og anvendelse heraf | |
| DK3692009T3 (da) | Biocementationsfremgangsmåde og system | |
| DK3157522T3 (da) | Muskarin-antagonister og kombinationer deraf til behandlingen af luftvejssygdomme i heste | |
| DK3458650T3 (da) | Fremgangsmåde til desinficering og vandhaneforbindelsesarrangement dertil |